AN2 Therapeutics (ANTX)
(Delayed Data from NSDQ)
$2.56 USD
+0.02 (0.79%)
Updated May 3, 2024 04:00 PM ET
After-Market: $2.55 -0.01 (-0.39%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.61 | -1.37% |
Earnings Summary
For their last quarter, AN2 Therapeutics (ANTX) reported earnings of -$0.57 per share, beating the Zacks Consensus Estimate of $-0.71 per share. This reflects a positive earnings surprise of 19.72%. Look out for ANTX's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.61 per share, reflecting a year-over-year increase of 22.78%.
Earnings History
Price & Consensus
Zacks News for ANTX
AN2 Therapeutics, Inc. (ANTX) Is a Great Choice for 'Trend' Investors, Here's Why
ANTX: What are Zacks experts saying now?
Zacks Private Portfolio Services